Wugen
Wugen is an off-the-shelf Cell Therapies for Cancer founded by Matthew Cooper, Todd Fehniger, Melissa Berrien-Elliott and John DiPersio.
1
Funding Rounds
$172.0m
Money raised
Overview
Wugen is an off-the-shelf Cell Therapies for Cancer founded by Matthew Cooper, Todd Fehniger, Melissa Berrien-Elliott and John DiPersio.
-
Website:
- Social accounts:
Funding series
Funding Series Analysis
The company Wugen has raised a total of $172m in funding over 1 rounds.
Key Insights:
- Wugen Series B round, July 2021: $172m
Wugen Series B round, July 2021
$172m
Industries
Wugen is active in the following industries: